NitroMed said last week that it had appointed Christopher Sobecki to its board of directors. Sobecki is currently a managing director of the Invus Group, a New York-based private equity and investment management firm with ownership in NitroMed. NitroMed's board now has nine board members.
Sobecki joined the Invus Group in 1989, and currently sits on the board of Weight Watchers International, GoldenSource, and Eduventures. He holds a BS in Industrial Engineering from Purdue University and an MBA from Harvard Business School.
Germany-based IntegraGen said last week it had appointed Jörg Leenings as head of sales and marketing for its competence center for maturity onset diabetes of the young and other genetic causes of diabetes.
Leenings was employed by Bio-Rad Laboratories for 15 years, most recently as group product manager and sales and marketing manager in Munich. Prior to that position, he worked for Abbott GmbH for 6 years. Leenings has also worked as a consultant, coordinating clinical studies for new products to achieve CE certification and FDA approval, IntegraGen said.
He received his diploma in chemical engineering from Aachen University of Applied Sciences.
DNAPrint said last week said it had appointed two new scientists to positions in the computational biology division of its subsidiary, DNAPrint Pharmaceuticals.
Tandy Herren was named director of simulation technology and Neil Kabrun was named director of biological modeling. Herren will be charged with applying modeling techniques in the company's drug and diagnostics product development programs, while Kabrun will apply computational methods to improving product development, the company said.
Herren previously worked for Kenna Technologies, which was acquired by DNAPrint Genomics in November 2005, and is a co-inventor of DNAPrint Pharmaceuticals' simulation methods. She earned a PhD in social psychology from Ohio State University, and holds two patents in the biological modeling industry.
Kabrun served as an independent consultant before joining DNAPrint Pharmaceuticals. He has also held positions at Transgenomic and Genomica. Kabrun earned his PhD in molecular microbiology at the State University of New York, Stony Brook, along with an MS in computer science.
Several top Affymetrix officials and scientists were recently named 'European Inventors of the Year' by the European Patent Office in the small to medium-sized enterprise category.
Affymetrix founder, chairman and CEO, Stephen Fodor, Affy scientific advisory board chairman Lubert Stryer, as well as company scientists Leighton Read and Michael Pirrung all received the award, which recognized the inventors for being the first to file patents on high-density microarray technology.
Paul Clark has joined the board of directors of Agilent Technologies, the company said last week.
Clark is the chairman, president and CEO of ICOS Corp., a Bothell, Wash.-based healthcare products company. Prior to joining ICOS, Clark served as executive vice president and board member of Abbott Laboratories, and held executive positions with Marion Laboratories and Sandoz Pharmaceuticals.
Oxford Gene Technology this week launched an E. coli K12 chromatin immunoprecipitation chip, its first microarray product, and part of its Prokaryotic Chip2 family of microarrays, the company said.
According to OGT, the Chip2 microarrays can be used to identify the binding positions of DNA binding proteins in a cell, analyze specific changes under various environmental conditions, operate as a model system to understand gene regulation, or reveal therapeutic targets against a prokaryotic species.
The chip has a probe density of 22,000 oligonucleotide features, and data generated can be analyzed in relation to its relative gene position using an OGT-developed ChIP browser, reducing the time taken to analyze the data, OGT said.
Jivan Biologics last week launched its Genome-Wide Mouse Splice Variant Microarray. The company claims that the array can interrogate hundreds of thousands of alternate RNA splicing events in the mouse genome, and enable scientists to quantify the expression of specific splice products rather than mere genes.
Jivan said sample labeling, hybridization, and data analysis are available through services offered by NimbleGen Systems and MoGene. Catalogue arrays manufactured by NimbleGen and Agilent Technologies are also available.
SciGene last week introduced its BriteSpot Microarray Workstation for genomic and proteomic research. The company claims the workstation can standardize and automate microarray hybridization, washing, and drying in an ozone-safe environment.
According to SciGene, the BriteSpot Workstation also minimizes data variation from non-biological sources.